The Amendment Group was founded by Chairman Xiu Laigui in May 1995. It is a large-scale modern private pharmaceutical enterprise integrating the scientific research, production and marketing of Chinese patent medicines, chemical pharmaceuticals, and biopharmaceuticals, drug chain operations, and standard cultivation of Chinese medicinal materials.
The revision group has 127 subsidiaries with more than 170,000 employees. It has 24 dosage forms, more than 2000 varieties of medicine and health products. The revision group has been booming for many years and its scale has been expanding. Its revenue will 60 billion in 2018, 70 billion in 2019 and 100 billion in 2020. What we offer:
1) Good quality control
2) Highly competitive prices
3) state-of-art technology products
4) Best professional team of lifestyle consumer electronics.
5) Smooth communication
6) Effective OEM&ODM service
Company advantage:1. Strong scientific research force, sufficient talent reserves, advanced corporate culture, world-class automatic production line, strong marketing ability (2019 Top 500 Chinese Brands, 2020 China's Over-the-Counter Drug Manufacturers, 2021 Private Enterprises Scientific and Technological Innovation Influence Ninth) 2. The Amendment Group has a nationally recognized enterprise technology center, a national engineering laboratory for quality control technology of traditional Chinese medicines, a postdoctoral research station, and a key laboratory of key engineering technology for standardization of traditional Chinese medicines. The Group's Science and Technology Innovation Center has 6 research institutes, including Beijing Revised New Drug Research Institute, Revised Biomedicine (Hangzhou) Research Institute, and Beijing Medicinal And Diet Research Institute, and its R&D conditions, technical capabilities, R&D achievements storage, patents and other aspects are in a leading position in the industry. 3. 77 product modernization quality inspection and control processes to ensure the quality and safety of drugs, production quality standards are higher than the national GMP standards. Original full traceability quality management service system, the introduction of Italian equipment for each box of drugs packaging sprayed with laser anti-counterfeiting code, each box of drugs have a unique "identity number", can be traced back to each box of drugs production, quality inspection, sales and other service links. 4. The Revision Group has eight health industry production bases in China, with ultra-high quality manufacturing leading capabilities and product technology content to achieve independent research and development, production, packaging and sales.
